UNC10112785 is a serine/threonine kinase inhibitor with a human GSK-3β IC 50 of 0.031 μM, human CDK-2 IC 50 of 0.016 μM, and human CDK-4 IC 50 of 1.99 μM. UNC10112785 can be used for the research of type 2 diabetes.
Products | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Type 2 Diabetes | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > GSK-3 | Products > Signaling Pathways > CDK | Products > Signaling Pathways > Ser/Thr Kinase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.